Carcinogenesis Advance Access originally published online on July 13, 2005
Carcinogenesis 2005 26(12):2213; doi:10.1093/carcin/bgi181
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis vol.26 no.12 © Oxford University Press 2005; all rights reserved.
LETTER TO THE EDITOR |
Reply: a bias in genotyping of the ERBB2 (HER2) Ile655Val variant
Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Wort's Causeway, Cambridge CB1 8RN, UK
* To whom correspondence should be addressed. Email: pbenusiglio@yahoo.com
| The first 10% of the full text of this article appears below. |
Dear Sir,
In a recent study of the neighbouring ERBB2 single nucleotide polymorphisms (SNPs) Ile654Val and Ile655Val, Frank et al. concluded that TaqMan genotyping of Ile655Val provided inaccurate results (1). In their assay, a valine at position 654 interfered with the correct binding of